SRI International


SRI International is an independent nonprofit research institute with a rich history of supporting government and industry. For almost 80 years, SRI has collaborated across technical and scientific disciplines to discover and develop groundbreaking products and technologies, delivering world-changing solutions for a safer, healthier, and more sustainable future. The Nomura-SRI Innovation Center (NSIC) further enhances SRI's mission by bridging the gap between Japan and Silicon Valley, fostering corporate innovation and talent development.

Industries

N/A

SRI International


Products

Cell-selective intracellular delivery platform

Platform for selective delivery of macromolecular therapeutics into targeted cell types and subcellular locations for research and therapeutic applications.

Lipid-based immunotherapy delivery platform

Lipid-carrier platform for antigen delivery to enhance immune responses and support immunotherapy development workflows.

Non-natural polymer discovery platform

Rapid discovery and screening platform for non-natural polymers with protein-like properties for use as therapeutics, diagnostics, or delivery agents.

Curated genomic and organism-specific bioinformatics portals

Curated genome databases and web portals integrating genome annotations with analysis tools to support research and systems-biology studies.

Printed microreactor prototype for CO2-to-methanol conversion

Modular printed microreactor prototype designed for distributed conversion of CO2 and water to methanol using intermittent renewable electricity; includes additive-fabrication design, catalyst testing, and integrated control and monitoring systems to sustain production at low renewable supply levels.


Services

Commercial R&D and collaborative research services

Multidisciplinary R&D engagements from early-stage exploration through prototyping and development under either collaborative IP-generation or services-only models.

Clinical Trials Unit services

Clinical research services including study design, site operations, and trial management with experience in vaccines, countermeasures, pain, and neurology studies.

Diagnostics, biomarker, and biosensor development

Assay development, biomarker identification, and prototyping of biosensing devices for health monitoring and bioagent detection.

Microcircuit emulation and obsolete parts manufacturing

Emulation, replication, and production services for obsolete microcircuits to support lifecycle extension of mission-critical systems.

Product transition and manufacturing integration

Support for moving technologies from prototype to production including OEM/contract-manufacturer coordination, supply-chain planning, and distribution readiness.

Venture formation, IP licensing, and startup incubation

Investment, intellectual-property transfer, incubation, and business development support to form and scale technology startups and spinouts.

View All Services

Expertise Areas

  • Drug discovery and preclinical development
  • Clinical trial management
  • Diagnostics and biomarker development
  • Drug and nucleic-acid delivery technologies
  • Show More (17)

Key Technologies

  • Machine learning and explainable AI
  • Neurosymbolic AI
  • Physics-informed machine learning
  • Abstraction-based sim-to-real transfer methods
  • Show More (22)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.